Journal article

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): A prospectively stratified randomised trial

Abstract:: Background: Therapeutic antibodies targeting EGFR have activity in advanced colorectal cancer, but results from clinical trials are inconsistent and the population in which most benefit is derived is uncertain. Our aim was to assess the addition of panitumumab to irinotecan in pretreated advanced colorectal cancer. Methods: In this open-label, randomised trial, we enrolled patients who had advanced colorectal cancer progressing after fluoropyrimidine treatment with or without oxaliplatin from...
Expand abstract
Collapse abstract

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Seymour, M., Brown, S. R., Middleton, G., Maughan, T., Richman, S., Gwyther, S., Lowe, C., Seligmann, J., Wadsley, J., Maisey, N., Chau, I., Hill, M., Dawson, L., Falk, S., O'Callaghan, A., Benstead, K., Chambers, P., Oliver, A., Marshall, H., … Quirke, P. (2013). Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): A prospectively stratified randomised trial. Lancet Oncology, 14(8), 749–759.

MLA Style

Seymour, M., et al. “Panitumumab and Irinotecan versus Irinotecan Alone for Patients with KRAS Wild-Type, Fluorouracil-Resistant Advanced Colorectal Cancer (PICCOLO): A Prospectively Stratified Randomised Trial.” Lancet Oncology, vol. 14, no. 8, 2013, pp. 749–59.

Chicago Style

Seymour, M, SR Brown, G Middleton, T Maughan, S Richman, S Gwyther, C Lowe, et al. 2013. “Panitumumab and Irinotecan versus Irinotecan Alone for Patients with KRAS Wild-Type, Fluorouracil-Resistant Advanced Colorectal Cancer (PICCOLO): A Prospectively Stratified Randomised Trial.” Lancet Oncology 14 (8): 749–59.
Share
Print

Access Document

Publisher copy:: 10.1016/S1470-2045(13)70163-3

Authors

+ Seymour, M More by this author

Role:: Author

+ Brown, SR More by this author

Role:: Author

+ Middleton, G More by this author

Role:: Author

+ Maughan, T More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Oncology
Role:: Author

+ Richman, S More by this author

Role:: Author

More authors...

Journal:: Lancet Oncology More from this journal
Volume:: 14
Issue:: 8
Pages:: 749-759
Publication date:: 2013-07-01
DOI:: 10.1016/S1470-2045(13)70163-3
EISSN:: 1474-5488
ISSN:: 1470-2045

Language:: English
Pubs id:: pubs:412058
UUID:: uuid:121b0ad2-3228-47d9-b8ba-89ba4d86be17
Local pid:: pubs:412058
Source identifiers:: 412058
Deposit date:: 2013-11-16

Terms of use

Copyright date:: 2013

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP